Issue 8/2008
Content (15 Articles)
Anti-angiogenic active immunotherapy: a new approach to cancer treatment
Jianping Pan, Pengfeng Jin, Jie Yan, Dieter Kabelitz
The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients
Takuya Osada, Gabriel Chong, Robert Tansik, Timothy Hong, Neil Spector, Rakesh Kumar, Herbert I. Hurwitz, Inderjit Dev, Andrew B. Nixon, H. Kim Lyerly, Timothy Clay, Michael A. Morse
Different immune correlates associated with tumor progression and regression: implications for prevention and treatment of cancer
Duane H. Hamilton, Peter A. Bretscher
Activation of extracellular signaling regulated kinase in natural killer cells and monocytes following IL-2 stimulation in vitro and in patients undergoing IL-2 immunotherapy: analysis via dual parameter flow-cytometric assay
Sri Vidya Kondadasula, Kimberly A. Varker, Gregory B. Lesinski, Don M. Benson Jr, Amy Lehman, Thomas Olencki, J. Paul Monk, Kari Kendra, William E. Carson III
CD40 ligation in vivo can induce T cell independent antitumor effects even against immunogenic tumors
Alexander L. Rakhmilevich, Ilia N. Buhtoiarov, Miroslav Malkovsky, Paul M. Sondel
Delivery of mengovirus-derived RNA replicons into tumoural liver enhances the anti-tumour efficacy of a peripheral peptide-based vaccine
Jean-Pierre Couty, Anne-Marie Crain, Sylvie Gerbaud, Marilyne Labasque, Carmen Marchiol, Didier Fradelizi, Sarah Boudaly, Catherine Guettier, Marco Vignuzzi, Sylvie van der Werf, Nicolas Escriou, Mireille Viguier
Use of radiolabeled monoclonal antibody to enhance vaccine-mediated antitumor effects
Mala Chakraborty, Alexander Gelbard, Jorge A. Carrasquillo, Sarah Yu, Marcelo Mamede, Chang H. Paik, Kevin Camphausen, Jeffrey Schlom, James W. Hodge
Recognition of naturally processed and ovarian cancer reactive CD8+ T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1
Junko Matsuzaki, Feng Qian, Immanuel Luescher, Shashikant Lele, Gerd Ritter, Protul A. Shrikant, Sacha Gnjatic, Lloyd J. Old, Kunle Odunsi
TGFβ secreted by B16 melanoma antagonizes cancer gene immunotherapy bystander effect
Claudia Penafuerte, Jacques Galipeau
Serum antibodies against Saccharomyces cerevisiae: a new prognostic indicator in metastatic renal-cell carcinoma
Reinhold Ramoner, Andrea Rahm, Hubert Gander, Björn Stollenwerk, Claudia Falkensammer, Nicolai Leonhartsberger, Martin Thurnher
Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response
Darja Kanduc, Luciana Tessitore, Guglielmo Lucchese, Anthony Kusalik, Emanuel Farber, Francesco M. Marincola
Preclinical studies in rats and squirrel monkeys for safety evaluation of the bivalent anti-human T cell immunotoxin, A-dmDT390–bisFv(UCHT1)
Jung Hee Woo, Sarah H. Bour, Tony Dang, Yu-Jen Lee, Seong Kyu Park, Elissa Andreas, Soo Hyun Kang, Jen-Sing Liu, David M. Neville Jr, Arthur E. Frankel
The anti-tumor agent, ingenol-3-angelate (PEP005), promotes the recruitment of cytotoxic neutrophils by activation of vascular endothelial cells in a PKC-δ dependent manner
Peter Hampson, Dean Kavanagh, Emily Smith, Keqing Wang, Janet M. Lord, G. Ed Rainger
The neoplastically transformed (CD30hi) Marek’s disease lymphoma cell phenotype most closely resembles T-regulatory cells
L. A. Shack, J. J. Buza, S. C. Burgess
Local secretion of anti-CTLA-4 enhances the therapeutic efficacy of a cancer immunotherapy with reduced evidence of systemic autoimmunity
Andrew D. Simmons, Marina Moskalenko, Jennifer Creson, Jianmin Fang, Saili Yi, Melinda J. VanRoey, James P. Allison, Karin Jooss